Application of tumor-derived IgG in diagnosis or prognosis of pancreatic cancer
A technology for use and prognosis, applied in the fields of medicine, clinical diagnosis, and prognosis, which can solve the problems of lack of molecular prognostic markers
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0062] The following trials were reviewed by the Ethics Committee of Peking Union Medical College Hospital of the Chinese Academy of Medical Sciences and abided by the Declaration of Helsinki. All patients were informed of the purpose of sample collection and storage and signed a written consent form.
[0063] 1. Case and trial design
[0064] Included in the pathological examination of 326 patients who had undergone radical surgery and were diagnosed as pancreatic ductal adenocarcinoma with tumor and paracancerous tissue specimens. The pathological diagnosis and staging standards refer to the seventh edition of the American Cancer Society Cancer Staging Manual.
[0065] The exclusion criteria included: preoperative chemotherapy and radiotherapy, perioperative death, receiving chemotherapy regimens other than gemcitabine and S1, and lack of follow-up data. Through age and gender matching, 326 cases were stratified and randomly divided into training set and validation set, both of wh...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com